NCT03288181

Brief Summary

Patients with peripheral arterial disease often have walking impairment due to insufficient oxygen supply to lower extremity skeletal muscle. In an aging rat model, we have previously shown that daily calf muscle stretching improves endothelium-dependent dilation of soleus muscle arterioles and blood flow during exercise. The effect of muscle stretching on endothelial function and walking distance in patients with peripheral arterial disease is unknown. We performed a prospective, randomized, non-blinded, crossover study in 13 patients with stable symptomatic peripheral artery disease. Patients were randomized to undergo either 4 weeks of passive calf muscle stretching (ankle dorsiflexion splints applied 30 minutes/day, 5 days/week) followed by 4 weeks of no muscle stretching (control group) and vice versa. Endothelium-dependent flow-mediated dilation and endothelium- independent nitroglycerin-induced dilation of the popliteal artery and a 6 minute walk test were evaluated at baseline and after each 4 week treatment interval. Patients crossed over to the other treatment arm after 4 weeks and endothelium-dependent flow-mediated dilation and endothelium- independent nitroglycerin-induced dilation of the popliteal artery and the 6 minute walk test were repeated.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
13

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2015

Shorter than P25 for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 5, 2015

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 30, 2016

Completed
16 days until next milestone

Study Completion

Last participant's last visit for all outcomes

June 15, 2016

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

September 15, 2017

Completed
4 days until next milestone

First Posted

Study publicly available on registry

September 19, 2017

Completed
Last Updated

September 19, 2017

Status Verified

September 1, 2017

Enrollment Period

8 months

First QC Date

September 15, 2017

Last Update Submit

September 15, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • Flow Mediated Dilatation of the Popliteal Artery

    Ultrasound assessment of flow mediated dilatation of the popliteal artery

    Performed 4 weeks after each intervention

Secondary Outcomes (1)

  • Six Minute Walk Test

    Performed 4 weeks after each intervention

Study Arms (2)

Muscle Stretch Group

EXPERIMENTAL

This is the group who applies the splint to stretch the calf muscles as per the described protocol for 4 weeks.

Device: Muscle Stretch

Control Arm

NO INTERVENTION

This is the group who has undergone no splint for 4 weeks.

Interventions

The splint will be applied to the affected leg as per the protocol for 30 minutes per day, 5 days per week for 4 weeks.

Muscle Stretch Group

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with stable symptomatic peripheral arterial disease

You may not qualify if:

  • critical limb ischemia
  • severe comorbid conditions that limit walking ability

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Peripheral Arterial DiseaseIntermittent Claudication

Condition Hierarchy (Ancestors)

AtherosclerosisArteriosclerosisArterial Occlusive DiseasesVascular DiseasesCardiovascular DiseasesPeripheral Vascular DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Wayne Batchelor, MD

    Tallahassee Research Institute

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 15, 2017

First Posted

September 19, 2017

Study Start

October 5, 2015

Primary Completion

May 30, 2016

Study Completion

June 15, 2016

Last Updated

September 19, 2017

Record last verified: 2017-09

Data Sharing

IPD Sharing
Will not share